| Literature DB >> 26850569 |
M T Eadon1, Z Desta1, K D Levy1, B S Decker1, R C Pierson1, V M Pratt2, J T Callaghan1,3, M B Rosenman4, J S Carpenter5, A M Holmes6, C A McDonald1, E A Benson1, A S Patil1,7, R Vuppalanchi1, B T Gufford1, N Dave1, J D Robarge1, M A Hyder1, D M Haas7, R P Kreutz1, P R Dexter8, T C Skaar1, D A Flockhart1.
Abstract
Hospital systems increasingly utilize pharmacogenomic testing to inform clinical prescribing. Successful implementation efforts have been modeled at many academic centers. In contrast, this report provides insights into the formation of a pharmacogenomics consultation service at a safety-net hospital, which predominantly serves low-income, uninsured, and vulnerable populations. The report describes the INdiana GENomics Implementation: an Opportunity for the UnderServed (INGENIOUS) trial and addresses concerns of adjudication, credentialing, and funding.Entities:
Mesh：
Year: 2016 PMID： 26850569 PMCID： PMC4899152 DOI： 10.1002/cpt.347
Source DB: PubMed Journal: Clin Pharmacol Ther ISSN： 0009-9236 Impact factor: 6.875